Prostate Cancer Withdrawn Phase 2 Trials for DB09331 (Daratumumab)

Also known as: Prostatic Cancer / Prostatic neoplasms malignant / Carcinoma Prostate / Cancer Of Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Prostate carcinoma / Carcinoma of the prostate / Cancer, Prostate / Carcinoma of prostate / Prostatic carcinoma / Carcinoma prostatic / Ca prostate / Prostate cancer NOS

IndicationStatusPhase
DBCOND0062462 (Prostate Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03035357Neoadjuvant Listeria or Daratumumab in Prostate CancerTreatment